Exercise-induced improvement in atrial depolarization abnormality in a patient after treatment with beta-adrenergic blockers

Cardiology

Volumn 111, Issue 1, 2008, Pages 36-40

  Ariyarajah, Vignendra ^a,c   Shaikh, Nasir ^a   Spodick, David H ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c Bergen Cardiac Care Center   (Canada)

Author keywords

Adrenergic blocker; Advanced interatrial block; Atrial depolarization; Exercise induced depolarization changes; Partial interatrial block

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

AGED; ARTICLE; CARDIAC PATIENT; CASE REPORT; DISEASE SEVERITY; ELECTROCARDIOGRAM; EXERCISE; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; LOW DRUG DOSE; MALE; P WAVE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ADRENERGIC BETA-ANTAGONISTS; AGED; ELECTROCARDIOGRAPHY; EXERCISE; HEART BLOCK; HUMANS; MALE;

EID: 48249137371     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000113425     Document Type: Article

References (13)

1. Bayes de Luna A: Electrocardiographic alterations due to atrial pathology; in Bayes de Luna A (ed): Clinical Electrocardiography: A Textbook. New York, Futura, 1998, pp 169-171.
2. Khaja A, Flaker G: Bachmann's bundle: Does it play a role in atrial fibrillation? Pacing Clin Electrophysiol 2005;28:855-863.
3. Ariyarajah V, Kranis M, Apiyasawat S, Spodick DH: Potential factors that affect electrocardiographic progression of interatrial block. Ann Noninvasive Electrocardiol 2007;12:21-26.
4. Ariyarajah V, Ali M, Spodick DH: Intermittent advanced atrial depolarization abnormality? Cardiology 2008;110:68-72.
5. Amar D, Shi W, Hogue CW Jr, Zhang H, Passman RS, Thomas B, Bach PB, Damiano R, Thaler HT: Clinical prediction rule for atrial fibrillation after coronary artery bypass grafting. J Am Coll Cardiol 2004;44:1248-1253.
6. Goyal SB, Spodick DH: Electromechanical dysfunction of the left atrium associated with interatrial block. Am Heart J 2001;142:823-827.
7. Bayes de Luna A, Cladellas M, Oter R, Torner P, Guindo J, Marti V, Rivera I, Iturralde P: Interatrial conduction block and retrograde activation of the left atrium and paroxysmal supraventricular tachyarrhythmias. Eur Heart J 1988;9:1112-1118.
8. Zaman AG, Kearney MT, Schecter C, Worthley SG, Nolan J: Angiotensin-converting enzyme inhibitors as adjunctive therapy in patients with persistent atrial fibrillation. Am Heart J 2004;147:823-827.
9. Madrid AH, Bueno MG, Rebollo JM, Marín I, Peña G, Bernal E, Rodriguez A, Cano L, Cano JM, Cabeza P, Moro C: Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study. Circulation 2002;106:331-336.
10. Yusuf S, Sleight P, Pogue J: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145-153.
11. Ariyarajah V, Apiyasawat S, Moorthi R, Spodick DH: Potential clinical correlates and risk factors for interatrial block. Cardiology 2006;105:213-218.
12. Dilaveris PE, Andrikopoulos GK, Metaxas G, Richter DJ, Avgeropoulou CK, Androulakis AM, Gialafos EJ, Michaelides AP, Toutouzas PK, Gialafos JE: Effects of ischemia on P wave dispersion and maximum P wave duration during spontaneous anginal episodes. Pacing Clin Electrophysiol 1999;22:1640-1647.
13. Porter KE, Turner NA, O'Regan DJ, Ball SG: Tumor necrosis factor alpha induces human atrial myofibroblast proliferation, invasion and MMP-9 secretion: inhibition by simvastatin. Cardiovasc Res 2004;64:507-515.